Commentary
Patients with T2DM and NAFLD exhibit higher risk of CVD compared with T2DM without NAFLD. In their review, C. Caussy et al. (Hopital Lyon Sud, France) underline that several studies have provided evidence that NAFLD could be an independent cardiovascular risk factor.
A potential synergistic increase of cardiovascular risk between T2DM and NAFLD is supported by several shared pathophysiological pathways. Thus, patients with T2DM and NAFLD should be considered at high risk of CVD and could benefit from more intensive CV prevention.
Hepatic inflammatory responses in liver fibrosis